epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Humalog Mix 75/ 25
    insulin lispro protamine/ insulin lispro
  • remove octreotide
    generic
  • remove Sinequan
    doxepin

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Humalog Mix 75/25 (insulin lispro protamine/ insulin lispro) + octreotide (generic)

Monitor/Modify Tx


insulin + octreotide

monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

Additional Considerations

Smiley face Smiley face doxepin in Sinequan

add MAO inhibitor to Interaction Check if recent (14 days) use

Smiley face Smiley face octreotide

caution advised with narrow therapeutic index drugs extensively metabolized by CYP450 liver enzymes; octreotide inhibition of growth hormone production may decr. CYP450 metabolic function, incr. levels of concomitant drugs, risk of adverse effects

caution advised with oral drugs; octreotide alters nutrient absorption, may alter absorption of concomitant drugs, incr. risk of adverse effects or decr. efficacy

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information